Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00221988 · ClinicalTrials.gov registry record · NA
Effects of Keppra on Thinking, Emotions, and Balance in Elderly Healthy Volunteers
A NA study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00221988 is a NA study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT00221988, a NA study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Epilepsy is a common disorder with an incidence of about 6 per 1000. The incidence progressively increases above age 50. By age 75, the incidence is two to three fold compared with any age group. Unfortunately, older individuals are especially at risk to incur significant side effects to anti-epileptic drugs. A newer anti-epileptic drug may markedly improve seizure management in older individuals as it is removed by the kidneys and not the liver and does not interact with other medications. We expect it to be tolerated well in terms of effects on memory, thinking,balance, and walking. The current study assesses the side effects of levetiracetam in healthy volunteers aged 65 to 80. Use of healthy volunteers eliminates the effects of seizures on the outcome.
Interventions
- DRUG Levetiracetam (Keppra)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-03 |
| Est. Completion | 2007-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00221988
The ClinicalTrials.gov registry entry for NCT00221988 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Levetiracetam (Keppra) is the first listed.
NCT00221988 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00221988 about?
NCT00221988 is a clinical study titled "Effects of Keppra on Thinking, Emotions, and Balance in Elderly Healthy Volunteers". Epilepsy is a common disorder with an incidence of about 6 per 1000. The incidence progressively increases above age 50. By age 75, the incidence is two to three fold compared with any age group. Unfortunately, older individuals are especially at risk to incur significant side effects to anti-epilep...
What is the current status of trial NCT00221988?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2004-03. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00221988?
The interventions under investigation include: Levetiracetam (Keppra) (DRUG).
Who is sponsoring clinical trial NCT00221988?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.